A Salmonella nanoparticle mimic overcomes multidrug resistance in tumours

Regino Mercado-Lubo,Yuanwei Zhang,Liang Zhao,Kyle Rossi,Xiang Wu,Yekui Zou,Antonio Castillo,Jack Leonard,Rita Bortell,Dale L. Greiner,Leonard D. Shultz,Gang Han,Beth A. McCormick

DOI: https://doi.org/10.1038/ncomms12225

IF: 16.6

2016-01-01

Nature Communications

Abstract:Salmonella enterica serotype Typhimurium is a food-borne pathogen that also selectively grows in tumours and functionally decreases P-glycoprotein (P-gp), a multidrug resistance transporter. Here we report that the Salmonella type III secretion effector, SipA, is responsible for P-gp modulation through a pathway involving caspase-3. Mimicking the ability of Salmonella to reverse multidrug resistance, we constructed a gold nanoparticle system packaged with a SipA corona, and found this bacterial mimic not only accumulates in tumours but also reduces P-gp at a SipA dose significantly lower than free SipA. Moreover, the Salmonella nanoparticle mimic suppresses tumour growth with a concomitant reduction in P-gp when used with an existing chemotherapeutic drug (that is, doxorubicin). On the basis of our finding that the SipA Salmonella effector is fundamental for functionally decreasing P-gp, we engineered a nanoparticle mimic that both overcomes multidrug resistance in cancer cells and increases tumour sensitivity to conventional chemotherapeutics.